http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
IMPACT Silver Intersects 114.5 g/t Gold, 1,295 g/t Silver and 1.10% Copper over 0.61m Within 9.79 g/t Gold, 212 g/t Silver and 0.29% Copper over 9.49m on Carlos Pacheco Vein Extension at Noche Buena M
-
ASUS Recognized as one of America’s Best Employers for Company Culture in Forbes’ 2026 Ranking
-
BeyondTrust’s 13th Annual Microsoft Vulnerabilities Report Reveals Drop in Total Volume, But Surge in Critical Risk
-
Securitize, Inc. ("Securitize") Appoints Sunil Sabharwal to Board of Directors
-
Bond Launches the “Post-Feed” Social Network to Connect Your Memories
-
American Foundation for Suicide Prevention and The Jed Foundation Announce Intent to Merge as Equals; Becoming the Nation's Largest Nonprofit Organization Dedicated to Suicide Prevention Across the Li
-
Merck and Eisai report failed kidney cancer drug trial results
-
New California Training Academy To Power Next-Gen HVAC Innovation
-
Allogene Therapeutics expands cancer trial to South Korea, Australia
-
Riverbed Study Highlights Improving Data Quality is Critical to AI Success for 88% of Healthcare Organizations
-
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
-
WERD Studios Launches ClipFarm with Access to 3.2 Million Followers
-
Almost 80% of Gen Z and Millennials Use 'Survival Spending'
-
Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing
-
Eckrich Serves Up the Taste of Home and Feel-Good Moments with Campaign Celebrating Bold Flavor for Grilling Season
-
Coalfire to Operationalize Cloud Compliance with Google Cloud
-
Stewards Inc. names Shaun Quin as new CEO, Vincent Napolitano steps down
-
HII begins production of four additional ROMULUS unmanned vessels
-
Cogent Biosciences to present GIST trial data at ASCO meeting
-
Pepperidge Farm Introduces Limited-Edition Chessmen® Cookie Board in Collaboration with Interior Designer Nate Berkus
-
HII Accelerates ROMULUS USV Program: Four New ROMULUS Vessels Head into Production
-
Krystal Biotech to Report First Quarter 2026 Financial Results on May 4, 2026
-
Toshiba Social Media Leader Robert Catalano Earns Gold
-
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Lightbridge to Hold Business Update & First Quarter 2026 Earnings Conference Call on Tuesday, April 28 at 4 p.m. ET
-
Stewards Inc. Announces Planned CEO Succession as Shaun Quin Appointed Chief Executive Officer
-
Stansberry Asset Management Marks 10 Years of Growth and Evolution
-
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
-
DeFi Technologies portfolio firm Stablecorp launches QCAD on Kraken
-
ImmunityBio launches ANKTIVA cancer treatment in Saudi Arabia
-
Soluna expands partnership with Blockware, adding 3.3 MW capacity
-
Bitcoin Bancorp Accelerates Texas Expansion of Licensed Bitcoin ATM Network
-
Soluna Announces Fourth Expansion with Blockware, Surpassing 17 MW of Total Capacity
-
DeFi Technologies Announces Venture Portfolio Company Stablecorp's QCAD Is Now Live for Trading on Kraken
-
ImmunityBio Announces ANKTIVA® Is Now Available in Saudi Arabia for Bladder and Lung Cancer Patients; Market Entry Achieved Within Two Months of MENA Partnership
-
Ionis reports positive zilganersen data for Alexander disease
-
Genprex signs research deal with MD Anderson to study lung cancer biomarkers
-
Signal Advance Inc. (OTC:SIGL) Secures Second Major Patent, Strengthening Analog Guard(R) AI and Quantum-Resistant Encryption Platform
-
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting
-
3D Seismic Survey Materially Expands Lawson Natural Hydrogen Discovery Target Area
-
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
-
Pharmactive Launches Kyoh® for Hair Growth Support
-
Guardforce AI Reports Full Year 2025 Financial Results
-
Galway Metals Intersects 6.1 g/t Gold over 19.0m Including 18.3 g/t over 3.0m
-
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC
-
Merck and Eisai trial for kidney cancer combination therapy fails endpoints
-
Merck and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
-
Bitget lists Bitget BTC (BGBTC) for Spot Trading
-
Personalis presents clinical data on cancer monitoring technology at AACR
-
Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026

